Literature DB >> 10205115

The Di Bella multitherapy trial. Randomised controlled trials may not always be absolutely needed.

A Liberati, N Magrini, L Patoia, L Pagliaro.   

Abstract

Mesh：

Year:  1999        PMID： 10205115      PMCID： PMC1115462          DOI： 10.1136/bmj.318.7190.1073

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Di Bella's therapy: the last word? The evidence would be stronger if the researchers had randomised their studies.

Authors:  M Müllner
Journal:  BMJ       Date:  1999-01-23

2.  Italy starts trials for controversial cancer treatment.

Authors:  F Turone
Journal:  BMJ       Date:  1998-01-31

3.  Closing the books on Laetrile.

Authors:  A S Relman
Journal:  N Engl J Med       Date:  1982-01-28       Impact factor: 91.245

Review 4.  Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials.

Authors:  R G Simonetti; A Liberati; C Angiolini; L Pagliaro
Journal:  Ann Oncol       Date:  1997-02       Impact factor: 32.976

5.  Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy. Italian Study Group for the Di Bella Multitherapy Trails.

Authors: 
Journal:  BMJ       Date:  1999-01-23
  5 in total
  1 in total

1.  PartecipaSalute, an Italian project to involve lay people, patients' associations and scientific-medical representatives in the health debate.

Authors:  Paola Mosconi; Cinzia Colombo; Roberto Satolli; Alessandro Liberati
Journal:  Health Expect       Date:  2007-06       Impact factor: 3.377
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.